Alveolar Soft Part Sarcoma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Alveolar Soft Part Sarcoma

What is the definition of Alveolar Soft Part Sarcoma?
Alveolar soft part sarcoma (ASPS) is a rare, slow-growing soft tissue sarcoma. Although it has been described in a variety of locations, it most commonly develops on the lower extremities in adults and in the head and neck region of children. ASPS generally presents as a soft, pain-less lump that is often not associated with any additional signs and symptoms. In many cases, the condition is not diagnosed until the affected person develops symptoms of metastasis to other sites such as the lungs, bones, central nervous system and/or liver. The underlying cause of ASPS is poorly understood. Most cases occur sporadically in people with no family history of the condition.
What are the alternative names for Alveolar Soft Part Sarcoma?
  • Alveolar soft part sarcoma
  • ASPS
Who are the top Alveolar Soft Part Sarcoma Local Doctors?
Elite in Alveolar Soft Part Sarcoma
Hematology Oncology
Elite in Alveolar Soft Part Sarcoma
Hematology Oncology
Referral may be required

UPMC Hillman Cancer Center

5115 Centre Avenue, Hillman Cancer Center, 
Pittsburgh, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Elite provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.

Elite in Alveolar Soft Part Sarcoma
Hematology Oncology | Hematology | Oncology
Elite in Alveolar Soft Part Sarcoma
Hematology Oncology | Hematology | Oncology
Referral may be required

Dana-Farber Cancer Institute, Sarcoma And Bone Cancer Treatment Center

450 Brookline Avenue, 
Boston, MA 
Languages Spoken:
English
Offers Telehealth

Priscilla Merriam is a Hematologist Oncology specialist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Merriam is rated as an Elite provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Alveolar Soft Part Sarcoma, Liposarcoma, and Epithelioid Sarcoma. Dr. Merriam is board certified in Hematology, Internal Medicine, and Medical Oncology.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Alveolar Soft Part Sarcoma
Elite in Alveolar Soft Part Sarcoma
Referral may be required

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
Experience:
26+ years
Languages Spoken:
English
Offers Telehealth

I am a medical oncologist who focuses on bone and soft tissue cancers called sarcomas. I love spending time with my patients. They often have a sense of awareness about their condition that’s truly unique and rewarding. I partner with each patient so they know the full set of options available for treatment and can make an informed decision about the approach that is best for them. I’ve wanted to pursue medicine for as long as I can remember. I find cancer fascinating because of its ability to evade the immune system. The body fails to recognize cancer as being foreign. When I am not at work, I love spending time with my family and enjoy long distance running. Dr. Riedel is rated as an Elite provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Desmoid Tumor, and Angiosarcoma. Dr. Riedel is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology.

What are the latest Alveolar Soft Part Sarcoma Clinical Trials?
A Phase 2 Study of Atezolizumab With Selinexor in Alveolar Soft Part Sarcoma (AXIOM)

Summary: This phase II trial tests whether atezolizumab in combination with selinexor works to shrink tumors in patients with alveolar soft part sarcoma and whether the study drugs are better than the usual approach in treating this type of cancer. The usual approach is defined as care most people get for alveolar soft part sarcoma if they are not part of a clinical study, which includes treatment with rad...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase I Study of GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Participants With Selected Relapsed/Refractory GPNMB-Expressing Solid Tumours

Summary: Only enrolling in Canada. The purpose of this study is to identify the highest dose of GCAR1, a chimeric antigen receptor (CAR-T) cell therapy, that can be tolerated without causing very severe side effects, and to see what effects GCAR1 has on selected cancers

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center